1002 Pharmacokinetic studies on a novel HBV entry inhibitor Myrcludex B demonstrate HBV-receptor expression in rodents and dogs but not in cynomolgus monkeys
Publikation: Beiträge in Zeitschriften › Konferenz-Abstracts in Fachzeitschriften › Forschung › begutachtet
Standard
1002 Pharmacokinetic studies on a novel HBV entry inhibitor Myrcludex B demonstrate HBV-receptor expression in rodents and dogs but not in cynomolgus monkeys. / Schieck, A.; Meier, A.; Alexandrov, A. et al.
in: Journal of Hepatology, Jahrgang 51, Nr. 1, 01.04.2010, S. S387.Publikation: Beiträge in Zeitschriften › Konferenz-Abstracts in Fachzeitschriften › Forschung › begutachtet
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - 1002 Pharmacokinetic studies on a novel HBV entry inhibitor Myrcludex B demonstrate HBV-receptor expression in rodents and dogs but not in cynomolgus monkeys
AU - Schieck, A.
AU - Meier, A.
AU - Alexandrov, A.
AU - Leder, Christoph
AU - Romeis, P.
AU - Haberkorn, Uwe
AU - Mier, James W.
AU - Urban, S.
N1 - Conference code: 45
PY - 2010/4/1
Y1 - 2010/4/1
KW - Health sciences
U2 - 10.1016/s0168-8278(10)61003-3
DO - 10.1016/s0168-8278(10)61003-3
M3 - Conference abstract in journal
VL - 51
SP - S387
JO - Journal of Hepatology
JF - Journal of Hepatology
SN - 0168-8278
IS - 1
T2 - 45th International Liver Congress - ILC 2010
Y2 - 14 April 2010 through 18 April 2010
ER -